NYU Winthrop Hospital Department of Urology is conducting this clinical research study for men ages 50 and older who have symptomatic BPH.
This study will evaluate the safety and efficacy of the Medi-Tate iTIND device for men with symptomatic BPH compared to a control.
Participants will be randomly assigned to receive treatment with either the iTIND implantable device or a sham control procedure.
The device will be inserted into the prostate through a cystoscope (a camera inserted into the bladder), and removed after 5-7 days.
To be eligible for this clinical research study you must:
- Have Benign Prostatic Hyperplasia (BPH) with symptoms (including but not limited to urinary hesitancy, weak stream, sensation of incomplete emptying)
- Have not had previous prostate surgery
Please contact the Urology Research Coordinator at 516-535-1900 or email email@example.com for more information.